These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 18826602)
1. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells. Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602 [TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677 [TBL] [Abstract][Full Text] [Related]
3. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma. Jørgensen K; Davidson B; Flørenes VA Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673 [TBL] [Abstract][Full Text] [Related]
5. A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy. Goto Y; Matsuzaki Y; Kurihara S; Shimizu A; Okada T; Yamamoto K; Murata H; Takata M; Aburatani H; Hoon DS; Saida T; Kawakami Y Cancer Res; 2006 Apr; 66(8):4443-9. PubMed ID: 16618771 [TBL] [Abstract][Full Text] [Related]
6. A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer. Liu RZ; Graham K; Glubrecht DD; Lai R; Mackey JR; Godbout R J Pathol; 2012 Nov; 228(3):310-21. PubMed ID: 22322885 [TBL] [Abstract][Full Text] [Related]
7. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma. Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117 [TBL] [Abstract][Full Text] [Related]
8. Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Jørgensen K; Skrede M; Cruciani V; Mikalsen SO; Slipicevic A; Flørenes VA Biochem Biophys Res Commun; 2005 Apr; 329(1):266-74. PubMed ID: 15721302 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer. Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of cytoplasmic p27 expression in human melanoma. Chen G; Cheng Y; Zhang Z; Martinka M; Li G Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232 [TBL] [Abstract][Full Text] [Related]
12. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin. Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461 [TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours. Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion. Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927 [TBL] [Abstract][Full Text] [Related]
15. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment. Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366 [TBL] [Abstract][Full Text] [Related]
16. Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling. Umaru BA; Kagawa Y; Shil SK; Arakawa N; Pan Y; Miyazaki H; Kobayashi S; Yang S; Cheng A; Wang Y; Shinoda Y; Kiniwa Y; Okuyama R; Fukunaga K; Owada Y Pharm Res; 2021 Mar; 38(3):479-490. PubMed ID: 33646504 [TBL] [Abstract][Full Text] [Related]
17. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Petersson S; Shubbar E; Enerbäck L; Enerbäck C Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263 [TBL] [Abstract][Full Text] [Related]
18. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression. Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834 [TBL] [Abstract][Full Text] [Related]